PPAR alpha Agonist, MHY3200, Alleviates Renal Inflammation during Aging via Regulating ROS/Akt/FoxO1 Signaling
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- SCIEScopus
- 저널 순위
- JCR Q2Scopus Q2
- 저널
- MOLECULES26(11) · 2021
- 피인용
- Web of Science 16Scopus 17
- FWCI (Scopus)
- 0.99
- JCR IF
- JCR 2020 4.412
- ISSN
- 1420-3049
저자
- 김민조제1저자Department of Pharmacy, College of Pharmacy, Pusan National University, Geumjeong‐gu, Busan, 46241, Korea;
- 김대현Department of Pharmacy, College of Pharmacy, Pusan National University, Geumjeong‐gu, Busan, 46241, Korea;
- 방은진Department of Pharmacy, College of Pharmacy, Pusan National University, Geumjeong‐gu, Busan, 46241, Korea;
- 노상균Department of Pharmacy, College of Pharmacy, Pusan National University, Geumjeong‐gu, Busan, 46241, Korea;
- Chun, PusoonCollege of Pharmacy, Inje University, Gyeongsangnam‐do, Gimhae, 50834, Korea;
- Yokozawa, TakakoGraduate School Science and Engineering for Research, University of Toyama, Toyama, 930‐8555, Japan
- 문형룡교신저자Department of Pharmacy, College of Pharmacy, Pusan National University, Geumjeong‐gu, Busan, 46241, Korea;
- 정해영교신저자Department of Pharmacy, College of Pharmacy, Pusan National University, Geumjeong‐gu, Busan, 46241, Korea;
초록
PPAR alpha is a ligand-dependent transcription factor and its activation is known to play an important role in cell defense through anti-inflammatory and antioxidant effects. MHY3200 (2-[4-(5-chlorobenzo[d]thiazol-2-yl)phenoxy]-2,2-difluoroacetic acid), a novel benzothiazole-derived peroxisome proliferator-activated receptor alpha (PPAR alpha) agonist, is a synthesized PPAR alpha activator. This study examined the beneficial effects of MHY3200 on age-associated alterations in reactive oxygen species (ROS)/Akt/forkhead box (FoxO) 1 signaling in rat kidneys. Young (7-month-old) and old (22-month-old) rats were treated with MHY3200 (1 mg/kg body weight/day or 3 mg/kg body weight/day) for two weeks. MHY3200 treatment led to a notable decrease in triglyceride and insulin levels in serum from old rats. The elevated kidney ROS level, serum insulin level, and Akt phosphorylation in old rats were reduced following MHY3200 treatment; moreover, FoxO1 phosphorylation increased. MHY3200 treatment led to the increased level of FoxO1 and its target gene, MnSOD. MHY3200 suppressed cyclooxygenase-2 expression by activating PPAR alpha and inhibiting the activation of nuclear factor-kappa B (NF-kappa B) in the kidneys of old rats. Our results suggest that MHY3200 ameliorates age-associated renal inflammation by regulating NF-kappa B and FoxO1 via ROS/Akt signaling.
키워드
agingMHY3200ROSAktNF-kappa BinflammationTRANSCRIPTION FACTORSOXIDATIVE STRESSPEROXISOME PROLIFERATORACTIVATED RECEPTORSMODULATIONAGEFOXORESTRICTIONHYPOTHESISMETABOLISM
식별자
- Scopus EID
- 2-s2.0-85107424702
- WoS UID
- 000660362900001



로그인
연구물 목록으로